Showing results (941-950 of 6,712) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|April 9, 2021
Remodels the Immunosuppressive Tumor Microenvironment by Combination of Bacillus Calmette-Guérin and Anti-PD-L1 in an Orthotopic Triple-Negative Breast Cancer Mouse ModelYuan Lu, Xin Huang, Xiaoke Liu, et al.Oncotargets and Therapy|April 9, 2021
LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 PathwayJiandong Li, Xiaohu Xu, Dandan Zhang, et al.Oncotargets and Therapy|April 15, 2021
Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in CancerMengwei Wang, Tianwei Xu, Wenyan Feng, et al.Oncotargets and Therapy|November 7, 2022
Targeting of GIT1 by miR-149* in Breast Cancer Suppresses Cell Proliferation and Metastasis in vitro and Tumor Growth in vivo [Retraction]Oncotargets and Therapy|October 10, 2022
A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future ProspectsGeorgios Polychronidis, Anastasia Murtha-Lemekhova, Juri Fuchs, et al.Oncotargets and Therapy|September 30, 2022
Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells [Retraction]Oncotargets and Therapy|September 2, 2022
Overcoming Obstacles in Liquid Biopsy Developments for Prostate CancerAlbert Jang, Grant P Rauterkus, Ulka N Vaishampayan, et al.Oncotargets and Therapy|December 5, 2023
Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung CancerYan Huang, Shuang Dai, Wenlian Yin, et al.Oncotargets and Therapy|November 29, 2023
Oral Anlotinib Maintenance Therapy for an Advanced Malignant Peritoneal Mesothelioma Diagnosed by Laparoscopy After Initial Misdiagnosis to Obtain Longer Progression-Free Survival: Case Report and Literature ReviewFan-Jie Qu, Yi Zhou, Hai WangOncotargets and Therapy|November 29, 2023
Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma MarkerWilliam G NorthPageof 672